Matthias Alexander Clauss

Title: Matthias Alexander Clauss: Innovator in Lung Disease Treatment

Introduction

Matthias Alexander Clauss is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of medical research, particularly in the treatment of lung diseases. With a total of three patents to his name, Clauss has focused on innovative solutions to combat the effects of influenza and other lung-related conditions.

Latest Patents

One of Clauss's latest patents is titled "Emapii neutralizing antibody limits influenza A virus (IAV)-induced lung injury." This invention addresses the detrimental effects of EMAPII, a protein that activates monocytes and endothelial cells, leading to apoptosis in these cells. The patent outlines methods and compositions for treating or preventing lung injuries associated with IAV infections, including weight loss and lung edema. Another significant patent is for "Monoclonal antibody and antigens for diagnosing and treating lung disease and injury." This invention provides methods for diagnosing emphysema and COPD by detecting EMAP II levels in patients, offering a new approach to treating conditions linked to elevated EMAP II expression.

Career Highlights

Clauss has worked with prestigious institutions, including Indiana University and the United States Government as represented by the Department of Veterans Affairs. His work has been instrumental in advancing the understanding and treatment of lung diseases.

Collaborations

Throughout his career, Clauss has collaborated with esteemed colleagues such as Irina Petrache and Robert Voswinckel. These partnerships have contributed to the development of his innovative patents and research.

Conclusion

Matthias Alexander Clauss is a pioneering inventor whose work in lung disease treatment has the potential to significantly impact patient care. His patents reflect a commitment to advancing medical science and improving health outcomes for individuals suffering from respiratory conditions.